↓ Skip to main content

Dove Medical Press

Societal savings in patients with advanced non-squamous non-small-cell lung cancer receiving bevacizumab-based versus non-bevacizumab-based treatments in France, Germany, Italy, and Spain

Overview of attention for article published in ClinicoEconomics and Outcomes Research: CEOR, October 2012
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

policy
1 policy source

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
33 Mendeley